NeuroPace (NPCE) Net Income towards Common Stockholders (2020 - 2026)

NeuroPace has reported Net Income towards Common Stockholders for 7 years, with the latest figure at -$6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders changed 0.26% year-over-year to -$6.5 million; the trailing twelve-month figure through Mar 2026 stood at -$21.0 million (up 15.94% YoY), and the FY2025 full-year result was -$21.0 million, up 23.56% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$6.5 million, down from -$2.7 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was -$2.7 million in Q4 2025, with the low at -$12.6 million in Q2 2022.
• Average Net Income towards Common Stockholders over 5 years is -$7.9 million, with a median of -$7.6 million recorded in 2024.
• Year-over-year, Net Income towards Common Stockholders tumbled 101.12% in 2022 and soared 47.15% in 2025.
• Tracing NPCE's Net Income towards Common Stockholders over 5 years: stood at -$11.0 million in 2022, then jumped by 41.23% to -$6.5 million in 2023, then grew by 20.12% to -$5.2 million in 2024, then soared by 47.15% to -$2.7 million in 2025, then plunged by 139.06% to -$6.5 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$6.5 million (Q1 2026), -$2.7 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.

Peer Comparison